133 related articles for article (PubMed ID: 38401929)
21. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
O'Farrell HE; Bowman RV; Fong KM; Yang IA
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592
[TBL] [Abstract][Full Text] [Related]
22. Two microRNAs of plasma-derived small extracellular vesicles as biomarkers for metastatic non-small cell lung cancer.
Geng N; Qi Y; Qin W; Li S; Jin H; Jiang Y; Wang X; Wei S; Wang P
BMC Pulm Med; 2023 Jul; 23(1):259. PubMed ID: 37452310
[TBL] [Abstract][Full Text] [Related]
23. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.
Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G
BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958
[TBL] [Abstract][Full Text] [Related]
24. An integrated workflow for biomarker development using microRNAs in extracellular vesicles for cancer precision medicine.
Chen Y; Wu T; Zhu Z; Huang H; Zhang L; Goel A; Yang M; Wang X
Semin Cancer Biol; 2021 Sep; 74():134-155. PubMed ID: 33766650
[TBL] [Abstract][Full Text] [Related]
25. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
[TBL] [Abstract][Full Text] [Related]
26. Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs.
Karttunen J; Heiskanen M; Navarro-Ferrandis V; Das Gupta S; Lipponen A; Puhakka N; Rilla K; Koistinen A; Pitkänen A
J Extracell Vesicles; 2019; 8(1):1555410. PubMed ID: 30574280
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Methods for MicroRNA Isolation from Extracellular Vesicles Obtained from Ascitic Fluids.
Skryabin GO; Vinokurova SV; Elkina NV; Denisova DA; Beliaeva AA; Zhordania KI; Bagrov DV; Enikeev AD; Galetsky SA; Komelkov AV; Krasnoshekova GI; Tchevkina EM
Biochemistry (Mosc); 2022 Nov; 87(11):1354-1366. PubMed ID: 36509726
[TBL] [Abstract][Full Text] [Related]
28. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C
Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250
[TBL] [Abstract][Full Text] [Related]
29. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
Dong X; Chang M; Song X; Ding S; Xie L; Song X
Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
[TBL] [Abstract][Full Text] [Related]
30. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.
Ren W; Hou J; Yang C; Wang H; Wu S; Wu Y; Zhao X; Lu C
J Exp Clin Cancer Res; 2019 Feb; 38(1):62. PubMed ID: 30736829
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer.
Jiang YF; Wei SN; Geng N; Qin WW; He X; Wang XH; Qi YP; Song S; Wang P
Sci Rep; 2022 Oct; 12(1):17201. PubMed ID: 36229645
[TBL] [Abstract][Full Text] [Related]
32. Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.
Shi YJ; Fang YX; Tian TG; Chen WP; Sun Q; Guo FQ; Gong PQ; Li CM; Wang H; Hu ZQ; Li XX
J Transl Med; 2023 Jun; 21(1):421. PubMed ID: 37386465
[TBL] [Abstract][Full Text] [Related]
33. Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes.
Lakhter AJ; Pratt RE; Moore RE; Doucette KK; Maier BF; DiMeglio LA; Sims EK
Diabetologia; 2018 May; 61(5):1124-1134. PubMed ID: 29445851
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas13a-Based MicroRNA Detection in Tumor-Derived Extracellular Vesicles.
Hong JS; Son T; Castro CM; Im H
Adv Sci (Weinh); 2023 Aug; 10(24):e2301766. PubMed ID: 37340600
[TBL] [Abstract][Full Text] [Related]
35. Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC.
Shukuya T; Ghai V; Amann JM; Okimoto T; Shilo K; Kim TK; Wang K; Carbone DP
J Thorac Oncol; 2020 Nov; 15(11):1773-1781. PubMed ID: 32565389
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
37. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
39. Proteomics, Phosphoproteomics and Mirna Analysis of Circulating Extracellular Vesicles through Automated and High-Throughput Isolation.
Zhang H; Cai YH; Ding Y; Zhang G; Liu Y; Sun J; Yang Y; Zhan Z; Iliuk A; Gu Z; Gu Y; Tao WA
Cells; 2022 Jun; 11(13):. PubMed ID: 35805153
[TBL] [Abstract][Full Text] [Related]
40. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
